-
Mashup Score: 12Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study - 8 hour(s) ago
Coronary artery calcification (CAC) progresses rapidly in people with chronic kidney disease (CKD) compared with the general population. We studied the association between CAC progression and higher risks of atherosclerotic cardiovascular disease (CVD), congestive heart failure, and all-cause mortality among adults with CKD.
Source: www.ajkd.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 15
Jennifer Bergeron (@DrJennyBee) is an Assistant Professor of Medicine and the Assistant Nephrology Program Director at West Virginia University. She completed her residency at the University of Ver…
Source: ajkdblog.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 25Hyperkalemia in a Patient With Resolving Acute Kidney Injury - 20 hour(s) ago
A 70-year-old man with chronic kidney disease stage 3b owing to previous episodes of acute kidney injury (AKI) and ischemic colitis treated with end-ileostomy was admitted with atrial fibrillation with a rapid ventricular rate and hypotension. He was started on a heparin infusion and underwent cardioversion without resolution of arrhythmia. His hospital course was complicated by prerenal nonoliguric AKI owing to high ostomy output, decreased oral intake, and low blood pressure. His creatinine was 4.7mg/dL, up from a baseline of 2.4mg/dL, and serum potassium and bicarbonate levels were 5.6 mEq/L and 10 mEq/L, respectively (Table 1).
Source: www.ajkd.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 4
Growth monitoring is the bread and butter of general pediatric care. It becomes even more relevant in pediatric chronic kidney disease (CKD) given the high risk of growth failure in affected children. Ensuring appropriate growth is a difficult task for families and requires multidisciplinary support. Many underlying pathophysiological contributors to growth impairment in pediatric CKD, and medical approaches to their management, have been explored. However, it remains challenging to understand how to best support growth in this population in a way that makes the most tangible difference to the entire family’s quality of life.
Source: www.ajkd.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 127Disorders of Volume: Core Curriculum 2025 - 2 day(s) ago
Historically, the paradigm for all maladies was associated with an imbalance of the 4 humors: blood, black bile, yellow bile, and phlegm. Although our understanding of disease has evolved significantly since the time of Hippocrates, a similar cornerstone of inpatient and ambulatory care involves understanding and correcting imbalances of volume. The kidneys are the principal organs controlling extracellular volume, capable of both sensing and altering salt retention through multiple redundant pathways, including the sympathetic nervous system and the renin-angiotensin-aldosterone system.
Source: www.ajkd.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 10
Ankle-brachial index (ABI) is used to screen for vascular complications in the setting of diabetes. This study sought to examine the relationship of longitudinal ABI data and chronic kidney disease (CKD) progression in patients with type 2 diabetes mellitus (T2DM) and increased body mass index.
Source: www.ajkd.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 4Homozygosity for a Rare FASTKD2 Variant Resulting in an Adult Onset Autosomal Recessive Mitochondrial Podocytopathy - 2 day(s) ago
Mitochondrial cytopathies can have kidney involvement in up to half of cases. Their diagnosis is challenging due to phenotypic variability, lack of noninvasive tests to assess mitochondrial dysfunction, and genetic heterogeneity. We report on a young adult male with hypertrophic cardiomyopathy (HCM) and chronic kidney disease (CKD) with subnephrotic proteinuria who presented to the emergency department with kidney failure and hypervolemia requiring dialysis. A kidney biopsy showed focal segmental and global glomerulosclerosis, extensive foot process effacement, and abnormal mitochondria in podocytes and tubular epithelial cells; the genetic workup identified a rare FASTKD2 exon 2 variant, c.29G>C p.(Ser10Thr), in homozygosity; and functional mitochondrial assays in cultured skin fibroblasts showed reduction in FASTKD2 protein expression and moderate combined impairment in mitochondrial respiratory chain (MRC) assembly and function.
Source: www.ajkd.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 15
Jennifer Bergeron (@DrJennyBee) is an Assistant Professor of Medicine and the Assistant Nephrology Program Director at West Virginia University. She completed her residency at the University of Ver…
Source: ajkdblog.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 74Frailty in Kidney Disease: A Comprehensive Review to Advance Its Clinical and Research Applications - 3 day(s) ago
Frailty is a multi-system syndrome of decreased physiologic reserve that has been shown to strongly and independently predict morbidity and mortality. Frailty is prevalent in patients living with kidney disease and occurs earlier in individuals with kidney disease as compared to the general population. In this comprehensive review, we aim to advance the clinical and research applications of frailty in kidney disease populations. Specifically, we clarify the definition of frailty and address its common misconceptions; review the mechanisms and epidemiology of frailty in kidney disease; discuss challenges and limitations in frailty measurement; and provide updated evidence related to risk factors for frailty, its associated adverse outcomes, and interventions.
Source: www.ajkd.orgCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 5Use of Statins for Primary Prevention Among Individuals with CKD in the United States: A Cross-Sectional, Time-Trend Analysis - 4 day(s) ago
Chronic kidney disease (CKD) populations face an elevated risk of cardiovascular disease (CVD), yet many remain undertreated with statins for primary prevention of CVD despite meeting eligibility criteria. We examined trends in statin use for primary prevention among individuals with CKD before and after the release of the 2013 Kidney Disease: Improving Global Outcomes (KDIGO) guideline recommending statin use for lipid management in selected adults with CKD.
Source: www.ajkd.orgCategories: General Medicine News, NephrologyTweet
Progression of Coronary Artery Calcification and Risk of Clinical Events in CKD: The Chronic Renal Insufficiency Cohort Study https://t.co/jMHHm85CsK #OpenAccess @byronjaeger1 @BudoffMd @RupalMehtaMD @CRICStudy https://t.co/eFQywX8u61